Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

Abstract Background Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints affecting 1% of the world population. It has major impact on patients through disability and associated comorbidities. Current treatment strategies have considerably improved the prognosis, but recent innov...

Full description

Bibliographic Details
Main Authors: Linda Hartman, Linda A. Rasch, Thomas Klausch, Hans W. J. Bijlsma, Robin Christensen, Yvo M. Smulders, Stuart H. Ralston, Frank Buttgereit, Maurizio Cutolo, Jose A. P. Da Silva, Daniela Opris, Jozef Rovenský, Szilvia Szamosi, Leonie M. Middelink, Willem F. Lems, Maarten Boers
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Trials
Subjects:
Rheumatoid arthritis
Elderly
Prednisolone
Glucocorticoids
Safety
Harm
Online Access:http://link.springer.com/article/10.1186/s13063-017-2396-3

Internet

http://link.springer.com/article/10.1186/s13063-017-2396-3

Similar Items